| Ms Nancy Lynn Zipperer, MA CCC-SLP | |
|
3821 Kohler Memorial Drive, Sheboygan, WI 53081 | |
| (920) 208-9648 | |
| (920) 208-6316 |
| Full Name | Ms Nancy Lynn Zipperer |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3821 Kohler Memorial Drive, Sheboygan, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184936155 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1662-154 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Nancy Lynn Zipperer, MA CCC-SLP 262 Ann Drive, Plymouth, WI 53073 Ph: (920) 207-7688 | Ms Nancy Lynn Zipperer, MA CCC-SLP 3821 Kohler Memorial Drive, Sheboygan, WI 53081 Ph: (920) 208-9648 |
News Archive
Each generation will make a distinctive mark on how and what Americans will be eating in 10 years, according to The NPD Group, a leading market research company. In its A Look into The Future of Eating report, NPD's food industry market research finds that eating patterns over the next decade will be influenced by the behaviors that occur with aging, and the differences in preferences from one generation to another.
Regulatory and commercial considerations are the primary drivers for successful biosimilar clinical development, according to a new report from Quintiles, titled An Integrated Approach to Biosimilar Development & Commercialization. In addition, the report states that successful biosimilar companies will be those who collapse their clinical, commercial, and regulatory thinking into a streamlined cohesive function as they proceed with developing biosimilars.
New research led by investigators at Beth Israel Deaconess Medical Center provides the first direct evidence linking traumatic brain injury to Alzheimer's disease and chronic traumatic encephalopathy (CTE) - and offers the potential for early intervention to prevent the development of these debilitating neurodegenerative diseases.
scientists with HerbalScience Group LLC, working with researchers from other organizations and medical institutions, conducted an in-depth study of optimized turmeric extracts, demonstrating that key bioactives in the botanical extracts inhibit aggregation and release of amyloid, a protein fragment considered a prime causal suspect in Alzheimer's disease.
› Verified 7 days ago
Mrs. Amy Laurell Krueger, MS-CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2508 Cooper Ave, Sheboygan, WI 53083 Phone: 920-889-5095 | |
Amy Marie Young, MS, CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3431 N 13th St, Sheboygan, WI 53083 Phone: 920-457-5046 Fax: 920-208-2713 | |
Mrs. Anneliese M Schneider, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3315 Behrens Pkwy, Sheboygan, WI 53081 Phone: 920-803-1617 Fax: 920-803-1622 | |
Sarah Luethy, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1902 Mead Ave, Sheboygan, WI 53081 Phone: 920-458-8333 Fax: 920-458-3346 | |
Annie Cai, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3821 Kohler Memorial Dr Ste 102, Sheboygan, WI 53081 Phone: 920-208-9648 | |
Miss Charysse M Gregorash, MS-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3315 Behrens Pkwy, Sheboygan, WI 53081 Phone: 920-803-1617 Fax: 920-803-1622 | |
Rachel Ann Keene, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1125 N 13th St, Sheboygan, WI 53081 Phone: 920-803-1617 Fax: 920-803-1622 |